Dr. Juandy Jo




Dr. Juandy Jo is a lecturer of Biotechnology Study Program. He earned his Degree of Medical Doctor from Universitas Gadjah Mada in Yogyakarta, Master of Molecular Biology from University of Queensland in Brisbane, Australia, and Doctor rerum naturalium. Research group of Prof. Dr. med. Robert Thimme Spemann from Graduate School of Biology and Medicine, Albert-Ludwigs-Universität Freiburg in Freiburg, Germany.


  • 2010 - Doctor rerum naturalium. Research group of Prof. Dr. med. Robert Thimme Spemann. Graduate School of Biology and Medicine, Albert-Ludwigs-Universität Freiburg, Freiburg, Germany
  • 2005 - Master of Molecular Biology. University of Queensland, Brisbane, Australia
  • 2003 - Medical Doctor. Gadjah Mada University, Yogyakarta, Indonesia
Post Doctoral Training:
  • 2019 - Danone Newgen Leadership Training (with Essec Business School)
  • 2019 - NICF-Certified Associate in Project Management
  • 2018 - Eureka-Singapore Monsoon School on Translational Medicine
  • 2016 & 2017 - ISO 9001:2015 Quality Management Systems Training
  • 2015 - ETC Drug Discovery Course
  • 2015 - SCDF Community Emergency Preparedness Programme
  • 2014 - Danone Finance for Non-Finance Training
  • 2013 - Sign – EMBO Workshop on Complex Systems in Immunology
Work Experiences:
  • 2020-now - Lecturer at Faculty of Science and Technology, Program of Biology, Pelita Harapan University, Tangerang, Indonesia
  • 2019-2020 - Senior Project Leader, Danone Nutricia Research, Singapore
  • 2018-2019 - Medical Affairs Manager (Secondment), Danone Nutricia Indonesia, Jakarta, Indonesia
  • 2017-2018 - Scientific Analytical Team Leader, Danone Nutricia Research, Singapore
  • 2015-2017 - Senior Immunology Scientist, Danone Nutricia Research, Singapore
  • 2013-2015 - Immunology Scientist, Danone Nutricia Research, Singapore
  • 2010-2013 - Research Fellow, Singapore Institute for Clinical Sciences, A*STAR, Singapore
  • 2006-2007 - Lecturer at Faculty of Medicine, Pelita Harapan University, Tangerang, Indonesia
Publication Journals:
  1. Gouw, J. W.*, Jo, J.*, Meulenbroek, L. A. P. M., Heijjer, T. S., Kremer, E., Sandalova, E., Knulst, A. C., Jeurink, P. V., Garssen, J., Rijnierse, A., & Knippels, L. M. J. (2018). Identification of peptides with tolerogenic potential in a hydrolysed whey-based infant formula. Clinical and Experimental Allergy: Journal of the British Society for Allergy and Clinical Immunology, 48(10), 1345-1353. doi: 10.1111/cea.13223
  2. Garssen, J., & Jo, J. (2017). Genetically-engineered T cells to treat viral hepatitis-associated liver cancer: is it possible? AIMS Allergy & Immunology, 1(1), 43-49. doi: 10.3934/Allergy.2017.1.43
  3. Tan-Garcia, A., Lu-En, W., Zheng, D., Ceccarello, E., Jo, J., Banu, N., Khakpoor, A., Chia, A., Tham, C. Y. L., Tan, A. T., Hong, M., Keng, C. T., Rivino, L., Tan, K. C., Lee, K. H., Lim, S. G., Newell, E. W., Pavelka, N., Chen, J., Ginhoux, F., Chen, Q., Bertoletti, A., & Dutertre, C-A. (2017). Intrahepatic CD206+ macrophages contribute to inflammation in advanced viral-related liver disease. Journal of Hepatology, 67(3), 490-500. doi: 10.1016/j.jhep.2017.04.02
  4. Jo, J., Garssen, J., Knippels, L., & Sandalova, E. (2014). Role of cellular immunity in cow’s milk allergy: pathogenesis, tolerance induction and beyond. Mediators of Inflammation, 2014, 1-10. doi: 10.1155/2014/249784
  5. Jo, J., Tan, A. T., Ussher, J. E., Sandalova, E., Tang, X.-Z., Tan-Garcia, A., To, N., Hong, M., Chia, A., Gill, U. S., Kennedy, P. T., Tan, K. C., Lee, K. H., Libero, G. D.,. Gehring, A. J., Willberg, C. B., Klenerman, P., & Bertoletti, A. (2014). Toll-like receptor 8 agonist and bacteria trigger potent activation of innate immune cells in human liver. PLoS Pathogens, 10(6), e1004210. doi: 10.1371/journal.ppat.1004210
  6. Fletcher, N. F., Sutaria, R., Jo, J., Barnes, A., Blahova, M., Meredith, L. W., Cosset, F.-L., Curbishley, S. M., Adams, D. H., Bertoletti, A., & McKeating, J. A. (2014). Activated macrophages promote hepatitis C virus entry in a tumor necrosis factor-dependent manner. Hepatology, 59(4), 1320-1330. doi: 10.1002/hep.26911
  7. Negash, A. A., Ramos, H. J., Crochet, N., Lau, D. T. Y., Doehle, B., Papic, N., Delker, D. A., Jo, J., Bertoletti, A., Hagedorn, C. H., & Gale, M. (2013). IL-1β production through the NLRP3 inflammasome by hepatic macrophages links hepatitis C virus infection with liver inflammation and disease. PLoS Pathogens, 9(4), e1003330. doi: 10.1371/journal.ppat.1003330
  8. Tang, X. Z.*, Jo, J.*, Tan, A. T.*, Sandalova, E.*, Chia, A., Tan, K. C., Lee, K. H.,. Gehring, A. J., Libero, G. D., & Bertoletti, A. (2013). IL-7 licenses activation of human liver intrasinusoidal mucosal-associated invariant T cells. The Journal of Immunology, 190(7), 3142-3152. doi: 10.4049/jimmunol.1203218
  9. Kennedy, P., Sandalova, E., Jo, J., Gill, U., Ushiro-Lumb, I., Tan, A. T., Naik, S., Foster, G., & Bertoletti, A. (2012). Preserved T cell function in children and young adults with immune tolerant chronic hepatitis B. Gastroenterology, 143(3), 637-645. doi: 10.1053/j.gastro.2012.06.009
  10. Jo, J., Bengsch, B., Seigel, B., Rau, S. J., Schmidt, J., Bisse, E., Aichele, P., Aichele, U., Joeckel, L., Royer, C., Ferreira, K. S., Borner, C., Baumert, T. F., Blum, H. E., Lohmann, V., Fischer, R., & Thimme, R. (2012). Low perforin expression of early differentiated HCV-specific CD8+ T cells limits their hepatotoxic potential. Journal of Hepatology, 57(1), 9- 16. doi: 10.1016/j.jhep.2012.02.030
  11. Jo, J., Lohmann, V., Bartenschlager, R., & Thimme, R. (2011). Experimental models to study the immunobiology of hepatitis C virus. The Journal of General Virology, 92(3), 477-493. doi: 10.1099/vir.0.027987-0
  12. Jo, J., Aichele, U., Kersting, N., Klein, R., Aichele, P., Bisse, E., Sewell, A. K., Blum, H. E., Bartenschlager, R., Lohmann, V., & Thimme, R. (2009). Analysis of CD8+ Tcell- mediated inhibition of hepatitis C virus replication using a novel immunological model. Gastroenterology, 136(4), 1391-1401. doi: 10.1053/j.gastro.2008.12.034
  13. Jo, J., Tan, A. T., & Bertoletti, A. (2013). Murine models and human studies of pathogenesis of chronic hepatitis B. In Howard C. Thomas, Anna S. F. Lok, Stephen A. Locarnini & Arie J. Zuckerman (Eds.) Viral Hepatitis, 4th edition (pp. 176-187). New Jersey: Wiley-Blackwell.
  14. GOUW, J. W., MEULENBROEK, L. A. P., JO, J., Johannes, K. L. M., & Garssen, J. (2019). Formula with specific beta-lactoglobulin peptides (World Intellectual Property Organization Patent No. WO2019212331A1). https://patents.google.com/patent/WO2019212331A1/en?oq=WO+2019%2f212331
  15. GOUW, J. W., MEULENBROEK, L. A. P. M., JO, J., Knippels, L. M. J., & Garssen, J. (2019). Formula with a specific beta-lactoglobulin peptide (World Intellectual Property Organization Patent No. WO2019212332A1). https://patents.google.com/patent/WO2019212332A1/en?oq=+WO%2f2019%2f212332
view Google Scholar (click here)